[
  {
    "entityLabels": [
      {
        "startCharIndex": 66,
        "entityName": "MeSH Term",
        "endCharIndex": 73
      },
      {
        "startCharIndex": 380,
        "entityName": "MeSH Term",
        "endCharIndex": 387
      },
      {
        "startCharIndex": 525,
        "entityName": "MeSH Term",
        "endCharIndex": 532
      },
      {
        "startCharIndex": 651,
        "entityName": "MeSH Term",
        "endCharIndex": 661
      },
      {
        "startCharIndex": 907,
        "entityName": "MeSH Term",
        "endCharIndex": 915
      },
      {
        "startCharIndex": 1189,
        "entityName": "MeSH Term",
        "endCharIndex": 1203
      },
      {
        "startCharIndex": 1219,
        "entityName": "MeSH Term",
        "endCharIndex": 1226
      }
    ],
    "intentName": "Description",
    "text": "\n1. G Ital Nefrol. 2018 Feb;35(1). pii: 2018-vol1.\n\n[Bardet-Biedl syndrome and Kidney failure: a case report].\n\n[Article in Italian]\n\nTattoli F(1), Falconi D(1), Bottaro C(1), Gherzi M(1), Marazzi F(1), Marengo\nM(1), Serra I(1), Tamagnone M(1), Formica M(1).\n\nAuthor information: \n(1)S.C. Nefrologia e Dialisi ASLCN1, Ospedali di Ceva, Mondov√¨, Savigliano e\nSaluzzo.\n\nBardet-Biedl Syndrome (BBS) is a rare multi-systemic disease with autosomal\nrecessive transmission. BBS was at first considered to be homogeneous as for its \ngenetics, but subsequent studies have shown an extensive gene variability.\nCurrently, 21 genes (BBS1-21) present on different chromosomes have been mapped: \nthese genes are responsible for BBS phenotypes and they show a great\nheterogeneity of mutations.The most common genes are BBS1 (locus 11q13) and\nBBS10.We show here the case of a 50 year old patient with BBS. Medical History:\nretinitis pigmentosa at 4 years of age evolved to complete blindness, generalized\nepilepsy crises, poly-syndactyly, left-hand malformation. In April 1986 developed\nan epileptic episode: on that occasion Chronic Kidney Failure (CKF) diagnosis and\nstarting of haemodialysis. In 1989, hospitalization for epileptic seizures. In\n2009 the patient underwent kidney transplantation from deceased donor.\nImmunosuppressive initial protocol: Basiliximab, Azathioprine, Tacrolimu"
  }
]